Walker Neal's Form 4 filing
Aclaris Therapeutics, Inc. (ACRS) · filed Jan 4, 2023
- Accession no.
- 0001209191-23-001329
- Filed
- Jan 4, 2023
- Trade date
- Jan 3-4, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $604.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walker NealCIK 0001604457 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock | SSaleDisposed | −23,382 | $15.19 | −$355,172.58 | 1,222,381 | Direct | |
| Jan 3, 2023 | Common Stock | SSaleDisposed | −1,618 | $16.16 | −$26,146.88 | 1,220,763 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −15,000 | $14.89 | −$223,350 | 1,205,763 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.